DPX Technologies LLC

DPX Technologies LLC is a for-profit limited liability company specializing in advanced analytical chemistry products and services, with a focus on providing laboratory consumables and scientific testing solutions to federal agencies. The company appears to have expertise in sample preparation and extraction technologies, particularly in developing high-throughput testing methodologies. While specific details about the company's origins or broader corporate structure are not explicitly provided, its federal award history demonstrates a strong capability in producing specialized laboratory equipment and participating in innovative research and development initiatives.

Through federal contract awards, DPX Technologies LLC has primarily provided specialized laboratory consumables, specifically solid phase extraction tips used in analytical chemistry applications. The company has been awarded delivery orders by the Defense Health Agency (DHA), focusing on supplying XTR TIPS: 10 MG SAX 60UM 1ML, a specific type of extraction tip used in scientific testing. These contracts have been competitively awarded without specific set-aside designations, indicating open competition. The contract values range from $4,162.50 to $23,976.00, suggesting the company works on relatively smaller but precise federal contract opportunities within the medical and scientific research domain.

In terms of federal grant awards, DPX Technologies LLC received a significant $254,536 Project Grant from the National Science Foundation under the SBIR PHASE I program. This grant, awarded between April 1, 2021, and September 30, 2021, was specifically focused on developing high-throughput COVID-19 testing solutions. The grant was provided through NSF's Directorate for Engineering and aimed to support engineering research and development, particularly in creating innovative products and services to enhance COVID-19 testing capacity through advanced engineering solutions.

DPX Technologies LLC holds two notable federal contract Indefinite Delivery Vehicles (IDVs) with the Defense Health Agency. The first is a single-award Indefinite Delivery Contract with a ceiling value of $119,880, running through April 30, 2029, for delivering XTR TIPS: 10 MG SAX 60UM 1ML. The second is a Blanket Purchase Agreement, also with a $119,880 ceiling, for DPX SOLID PHASE EXTRACTION TIPS, which was initially set to run through August 31, 2023. Both IDVs were awarded without set-aside designations and support the military health system's laboratory and testing requirements, demonstrating the company's specialized role in providing critical scientific and medical laboratory consumables.